Bristol Myers Squibb (BMY) Net Income - Minority (2009 - 2024)

Bristol Myers Squibb has disclosed Net Income - Minority across 15 years of filings, most recently posting -$58.0 million for Q3 2024.

• In Q3 2024, Net Income - Minority changed N/A year-over-year to -$58.0 million; the TTM figure through Sep 2024 stood at -$58.0 million (changed N/A YoY), while the FY2023 annual figure was -$55.0 million, changed N/A from the prior year.
• Net Income - Minority declined to -$58.0 million in Q3 2024, from -$54.0 million in the prior quarter.
• Over the last five years, Net Income - Minority for BMY reached as high as -$54.0 million in Q2 2024 and fell as low as -$72.0 million in Q3 2020.
• The 4-year median for Net Income - Minority is -$66.0 million (2020), against an average of -$63.6 million.
• Annual changes were most pronounced in 2020 — Net Income - Minority soared 40.0% — and 2021, when it slipped 3.03%.
• A 4-year view of Net Income - Minority shows it stood at -$60.0 million in 2020, then declined by 18.33% to -$71.0 million in 2021, then increased by 22.54% to -$55.0 million in 2023, then declined by 5.45% to -$58.0 million in 2024.
• According to Business Quant data, Net Income - Minority over the past three periods registered -$58.0 million, -$54.0 million, and -$55.0 million for Q3 2024, Q2 2024, and Q4 2023 respectively.